""

The Hopkins Business of Health Initiative hosts “Conversations on the Business of Health,” a series of one-hour webinars that engage leaders of business and academia on the cutting edge of improving American health care. Moderated by faculty members and jointly hosted by the Bloomberg School of Public Health, the Carey Business School, the School of Nursing, and the School of Medicine, the series is open to all.  Additional Co-Hosts have included the Center for Innovative Leadership, the Center for Mental Health and Addiction Policy, the HEADS Center, and the Digital Business Development Initiative. 

 

Upcoming Conversations
Friday, February 21, 2025 | Webinar

Featuring experts: Ceci Connolly, James P. Holland, and Ravi Gupta.

| Read More...
Friday, May 16, 2025 | Webinar

Featuring Paul Billings, Chief Executive Officer and Director, Biological Dynamics; Jordan J. Green, Director, Biomaterials and Drug Delivery Laboratory and Professor of Biomedical Engineering, Johns Hopkins University; Lilja Solnes, Associate Professor and Director of Nuclear Medicine and Molecular Imaging, Johns Hopkins University (TBC); John Steuart, Managing Director Steuart Ventures

| Read More...
Past Conversations
Fireside chat between HBHI's Director and Bloomberg Distinguished Professor, Dan Polsky, PhD and Ziad ​Obermeyer, MD, Blue Cross of California Distinguished Associate Professor, Health Policy and Management, University of California, Berkeley | Learn More...
The panel, moderated by Mario Macis, PhD, Professor at Johns Hopkins University, included Andrew Cameron, MD, Director of Johns Hopkins School of Medicine Dept of Surgery; Alexandra Glazier, CEO, New England Donor Services; Jean Moody-Williams, RN, MPP, Deputy Center Director for CMS; Denis Wagner, MPA, Principal and Director of YES and Leadership, LLC | Learn More...
The panel, moderated by Andrew Anderson, PhD, Assistant Professor at Johns Hopkins University, included Andy Higgins, VP of Product Development at Clever Care; Sachin Jain, CEO of SCAN Group and SCAN Health Plan; Mark Meiselbach, Assistant Professor at Johns Hopkins University; and Casey Schwarz, Senior Counsel for Federal Policy. | Learn More...
The panel, moderated by Bruce Leff, MD, Professor of Medicine at Johns Hopkins, included Ali Khan, MD, MPP, FACP, Vice President and Chief Medical Officer – Aetna Medicare, Aetna/CVS Health Company; Eliza Pippa Shulman, DO, MPH, Chief Medical Officer at Medically Home; and Kristofer L. Smith, MD, MPP, Past-Chief Medical Officer at Optum at Home. | Learn More...
HBHI and the Center for Health Systems and Policy Models (CHSPM) invited a panel of three guests to discuss this issue: Senator Richard Burr, Chair of DLA Piper’s health policy strategic consulting service; Michael Darden, PhD, academic program director for the Master of Science in healthcare management at the Carey School of Business; and Lauren Taylor, professor in the Department of Population Health at NYU Grossman School of Medicine. | Learn More...
HBHI convened an expert panel at the Hopkins Bloomberg Center in Washington, D.C. to discuss how the healthcare industry at large and providers at the grassroots level are working to bring about change. | Learn More...
Earth Day was the perfect occasion for the Hopkins Business of Health Initiative (HBHI) to host a first-of-its-kind conversation with HHS Secretary Xavier Becerra about addressing healthcare’s climate footprint in the context of environmental justice. | Learn More...
HBHI invited a panel of three guests to discuss this issue: Katey Bey, Global Head, Total Rewards, Sedgwick; Gregory Daniel, PhD, MPH, Vice President & Head of Global Public Policy, Eli Lilly and Company; and Shantanu Nundy, MD, EVP Care Delivery and Chief Health Officer, Accolade. | Learn More...

Expert panelists: Jim Rebitzer, PhD, and Bob Rebitzer.

This was an enlightening discussion with the authors of "Why Not Better and Cheaper?" We explored the unique challenges of healthcare innovation in the US and discussed why there's a lack of incentives for cost-reducing innovations and the ease of profiting from low-value innovations.

| Read the takeaways here...